Risperidone vs. bupropion ER [extended release] augmentation of SSRIs [serotonin reuptake inhibitors] in treatment-resistant depression

Trial Profile

Risperidone vs. bupropion ER [extended release] augmentation of SSRIs [serotonin reuptake inhibitors] in treatment-resistant depression

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Dec 2016

At a glance

  • Drugs Risperidone (Primary) ; Bupropion
  • Indications Major depressive disorder
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 01 Feb 2008 Status changed from in progress to completed according to NCT.
    • 23 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top